Nurix Therapeutics Inc Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket
 


Nurix Therapeutics Inc   (NASDAQ: NRIX)

NRIX's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Nov 30 2025)
2025
(Nov 30 2024)
2024
(Nov 30 2023)
2023
(Nov 30 2022)
2022
(Nov 30 2021)
2021
Y / Y Equity Change 2.23 % 162.85 % -33.98 % -11.28 % 17.93 %
Y / Y Net Income Change - - - - -
Return On Equity - - - - -


You need to upgrade your Flash Player


Financial Statements
Nurix Therapeutics Inc 's Equity $ 539 Millions Annual NRIX's Balance sheet
Nurix Therapeutics Inc 's Annual Income $ -264 Millions Annual NRIX's Income Statement
Where are NRIX's Income coming from? Visit NRIX's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.